Journal of Anaesthesiology Clinical Pharmacology

REVIEW ARTICLE
Year
: 2019  |  Volume : 35  |  Issue : 1  |  Page : 3--11

Anesthetic implications in hyperthermic intraperitoneal chemotherapy


Nishkarsh Gupta, Vinod Kumar, Rakesh Garg, Sachidanand Jee Bharti, Seema Mishra, Sushma Bhatnagar 
 Department of Onco-Anesthesiology and Palliative Medicine, DR BRAIRCH, AIIMS, New Delhi, India

Correspondence Address:
Nishkarsh Gupta
Department of Onco.Anesthesiology and Palliative Medicine, DR BRAIRCH, AIIMS, New Delhi
India

Patients with peritoneal carcinomatosis were considered incurable with dismal survival rates till hyperthermic intraperitoneal chemotherapy after optimal cytoreductive surgery evolved. Perioperative management for these procedures is complex and involves an optimal cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy. In this article we highlight the perioperative concerns in these patients including anesthetic challenges, such as optimal fluid management, maintaining blood pressure, control of body temperature, coagulation and electrolyte derangement and renal toxicity of chemotherapeutic drugs. We have also discussed the postoperative problems and their management.


How to cite this article:
Gupta N, Kumar V, Garg R, Bharti SJ, Mishra S, Bhatnagar S. Anesthetic implications in hyperthermic intraperitoneal chemotherapy.J Anaesthesiol Clin Pharmacol 2019;35:3-11


How to cite this URL:
Gupta N, Kumar V, Garg R, Bharti SJ, Mishra S, Bhatnagar S. Anesthetic implications in hyperthermic intraperitoneal chemotherapy. J Anaesthesiol Clin Pharmacol [serial online] 2019 [cited 2019 Jul 18 ];35:3-11
Available from: http://www.joacp.org/article.asp?issn=0970-9185;year=2019;volume=35;issue=1;spage=3;epage=11;aulast=Gupta;type=0